TOP: Trial of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis

This study has been completed.

Sponsor:

Information provided by:

NPS Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT00172081

First received: September 9, 2005

Last updated: January 20, 2009

Last verified: September 2005

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	November 2003
Estimated Primary Completion Date:	No date given

No publications provided by NPS Pharmaceuticals

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):